ClinicalTrials.Veeva

Menu

The Stroke Warning Information and Faster Treatment Study (SWIFT)

Columbia University logo

Columbia University

Status and phase

Terminated
Phase 2

Conditions

Stroke

Treatments

Behavioral: usual medical care
Behavioral: interactive educational program

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT00415389
P50NS049060 (U.S. NIH Grant/Contract)
AAAA9948

Details and patient eligibility

About

The purposes of this study are to determine the effectiveness of an interactive stroke educational program compared to standard educational materials and usual care, to increase stroke knowledge, and to improve emergency room arrival times upon onset of stroke symptoms.

Full description

Rapid diagnosis and treatment of acute ischemic stroke is critical to reduce disability and death caused by stroke. While recombinant tissue plasminogen activator, or rt-PA, is the only approved treatment for acute ischemic stroke, less than 2-3 percent of individuals with stroke actually receive treatment. The inability to capture acute ischemic stroke cases within 3 hours of symptom onset is one critical factor. Populations at highest risk for stroke are significantly undereducated about the need for rapid, intervention upon onset of stroke symptoms. This is especially true among vulnerable populations including African Americans, Hispanics, and the poor.

The purpose of this study is to evaluate the effectiveness of a 2-session, culturally-sensitive, interactive stroke educational program compared to standard educational materials and usual care. In this study, the scientists will determine if the interactive program increases knowledge about stroke, and results in earlier arrival to the emergency room in the case of stroke.

The study will enroll 1400 individuals who have had a stroke or transient ischemic attack (TIA). Participants will be randomized to receive usual medical care--which includes standard educational information on stroke, stroke warning signs and risk factors--or usual medical care plus a 2-session interactive stroke educational program. All participants will be administered pre and post (30 days and 1 year) intervention stroke knowledge/behavior surveys. In additional, participants will be contacted every 12 months to check health status and document new stroke events associated with emergency room arrival time.

The SWIFT study is part of the Specialized Program for Translational Research in Acute Stroke (SPOTRIAS), which seeks to understand why certain people may be at increased risk for stroke. The goal of the study is to increase stroke knowledge, change behavior, and improve emergency room arrival times upon onset of stroke symptoms.

Enrollment

1,635 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosed with cerebral infarction/TIA hospitalized at New York Presbyterian Hospital (Milstein Hospital and Allen Pavilion)
  • 18 year-old and older at onset of the stroke
  • Self-identified as of White, Black or Hispanic race-ethnicity
  • Living in a household with a telephone

Exclusion criteria

  • Patients unable to give informed consent
  • Discharged to nursing home or requiring 24 hour care.
  • A Modified Rankin score > 4 at baseline
  • Severe aphasia or severe cognitive impairment limiting comprehension
  • Pre-stroke dementia history
  • Patients with end stage cancer, or other medical conditions resulting in mortality </= 1 year

Trial design

1,635 participants in 2 patient groups

1
Active Comparator group
Description:
interactive educational program
Treatment:
Behavioral: interactive educational program
2
Active Comparator group
Description:
usual medical care
Treatment:
Behavioral: usual medical care

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems